Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project

Alzheimer's and Dementia

Volumn 11, Issue 2, 2015, Pages 161-174

  Duchesne, Simon ^a   Valdivia, Fernando ^a   Robitaille, Nicolas ^a   Mouiha, Abderazzak ^a   Valdivia, F Abiel ^a   Bocchetta, Martina ^b,c   Apostolova, Liana G ^d   Ganzola, Rossana ^a   Preboske, Greg ^e   Wolf, Dominik ^f   Boccardi, Marina ^b   Jack, Clifford R ^e   Frisoni, Giovanni B ^b,g  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MAYO CLINIC   (United States)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Alzheimer's disease; Area; Harmonized protocol; Hippocampal segmentation; Magnetic resonance imaging; Qualification platform; Qualitative criteria; Quantitative criteria; Spatial distance; Spatial overlap

Indexed keywords

BIOLOGICAL MARKER; TRACER;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DELPHI STUDY; HARMONIZED HIPPOCAMPAL SEGMENTATION PROTOCOL; HIPPOCAMPUS; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRAINING; VISUAL FEEDBACK; VOLUMETRY; ANATOMY AND HISTOLOGY; IMAGE PROCESSING; IN SERVICE TRAINING; MILD COGNITIVE IMPAIRMENT; ORGAN SIZE; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; THREE DIMENSIONAL IMAGING; VALIDATION STUDY;

ALZHEIMER DISEASE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; INSERVICE TRAINING; MAGNETIC RESONANCE IMAGING; MILD COGNITIVE IMPAIRMENT; ORGAN SIZE; REPRODUCIBILITY OF RESULTS;

EID: 84933529246     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.01.002     Document Type: Article

References (26)

1. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 2011;7:263-9.
2. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7:270-9.
3. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6:734-46.
4. Committee for Medicinal Products for Human Use. Qualification opinion of low hippocampal volume (atrophy) by MRI for use in clinical trials for regulatory purpose-in pre-dementia stage of Alzheimer's disease. EMA/CHMP; 17 November 2011.
5. Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 2008;27:685-91.
6. Geuze E, Vermetten E, Bremner JD. MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed. Mol Psychiatry 2005;10:147-59.
7. Konrad C, Ukas T, Nebel C, Arolt V, Toga AW, Narr KL. Defining the human hippocampus in cerebral magnetic resonance images-an overview of current segmentation protocols. NeuroImage 2009; 47:1185-95.
8. Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, et al. Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol. J Alzheimers Dis 2011;26(Suppl 3):61-75.
9. Frisoni GB, Jack CR Jr, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, et al. The EADC-ADNI harmonized protocol for hippocampal segmentation on magnetic resonance: Evidence of validity. Alzheimers Dement 2015;11:111-25.
10. Boccardi M, Bocchetta M, Ganzola R, Robitaille N, Redolfi A, Duchesne S, et al. Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation. Alzheimers Dement 2015;11:192-202.
11. Kaye JA, Swihart T, Howieson D, Dame A, Moore MM, Karnos T, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997; 48:1297-304.
12. Frisoni GB, Jack CR. Harmonization of magnetic resonance-based manual hippocampal segmentation: A mandatory step for wide clinical use. Alzheimers Dement 2011;7:171-4.
13. Boccardi M, Bocchetta M, Apostolova LG, Preboske G, Robitaille N, Pasqualetti P, et al. Establishing magnetic resonance images orientation for the EADC-ADNI manual hippocampal segmentation protocol. J Neuroimaging 2014;24:509-14.
14. Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CF, Askham J, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess 1998;2:1-88.
15. Boccardi M, Bocchetta M, Apostolovac LG, Barnes J, Bartzokis G, Corbetta G, et al. Delphi definition of the EADC-ADNI harmonized protocol for hippocampal segmentation on magnetic resonance. Alzheimers Dement 2015;11:126-38.
16. Bocchetta M, Boccardi M, Ganzola R, Apostolova LG, Preboske G, Wolf D, et al. Harmonized benchmark labels of the hippocampus on magnetic resonance: The EADC-ADNI project. Alzheimers Dement 2015;11:151-65.
17. Jannin P, Grova C, Maurer CR. Model for defining and reporting reference-based validation protocols in medical image processing. Int J Comp Assist Radiol Surg 2006;1:63-73.
18. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in "probable " Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967-72.
19. Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, et al. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement 2011;7:386-3956.
20. Hoglund K, Bogstedt A, Fabre S, Aziz A, Annas P, Basun H, et al. Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease. J Alzheimers Dis 2012;32:939-47.
21. Jack CR Jr, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, et al. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement 2011;7:474-4854.
22. Duchesne S. Appearance-based segmentation of medial temporal lobe structures. NeuroImage 2002;17:515-31.
23. Hasan KM, Pedraza O. Improving the reliability of manual and automated methods for hippocampal and amygdala volume measurements. Neuroimage 2009;48:497-8.
24. Barnes J, Foster J, Boyes RG, Pepple T, Moore EK. A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus. NeuroImage 2008;40:1655-71.
25. Brewer JB, Magda S, Airriess C, Smith ME. Fully-automated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease. AJNR Am J Neuroradiol 2009;30:578-80.
26. Boccardi M, Bocchetta M, Morency FC, Collins DL, Nishikawa M, Ganzola R, et al. Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol. Alzheimers Dement 2015;11:175-83.